Related Articles
Association between Toll-like receptor 7 Gln11Leu single-nucleotide polymorphism and basal cell carcinoma
Association of Toll‑like receptor 2 polymorphisms with gout
TLR7 agonist induced repression of hepatocellular carcinoma via the TLR7-IKK-NF-κB-IL6 signaling pathway
Low expression of Toll-like receptors in peripheral blood mononuclear cells of pediatric patients with acute lymphoblastic leukemia
Antitumor activity of a novel small molecule TLR7 agonist via immune response induction and tumor microenvironment modulation